Rhinitus/Sinusitis/Ocular Allergy News

Patients with prior sinusitis demonstrate an increased risk for many rheumatic diseases, including antiphospholipid syndrome, Sjögren’s disease and seronegative rheumatoid arthritis, according to data published in RMD Open.

Patients who believe they have allergic rhinitis really might have chronic rhinosinusitis, according to a study published in Otolaryngology – Head and Neck Surgery.

The FDA has approved fluticasone propionate nasal spray for the treatment of chronic rhinosinusitis without nasal polyps in patients aged 18 years and older, according to an Optinose press release.

An exhalation delivery system that uses fluticasone reduced symptoms and improved quality of life for patients with chronic rhinosinusitis, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Adolescents experienced better control of their rhinitis and asthma than young adults and adults, although all three age groups reported similar medication adherence, according to a study published in Pediatric Allergy and Immunology.

Jonathan A. Bernstein, MD, president of the American Academy of Allergy, Asthma & Immunology, is very excited about the group’s Annual Meeting, scheduled for Feb. 23-26 in Washington, D.C.

Researchers characterized the use of dupilumab among a cohort of patients with asthma, chronic rhinosinusitis with nasal polyps or both as persistent in a study published in Annals of Allergy, Asthma & Immunology.

Children who begin sublingual immunotherapy for allergic rhinitis at age 5 years have less risk for developing allergic asthma than children who begin this treatment later, according to a study published in Allergy.

Indoor metabolites and chemicals may be more accurate indicators of risks for childhood asthma and allergic rhinitis than the indoor microbiome, according to a study published in Eco-Environment and Health.

Patients with cystic fibrosis had improved chronic rhinosinusitis outcomes after 1 year of elexacaftor/tezacaftor/ivacaftor therapy, according to results published in JAMA Otolaryngology-Head & Neck Surgery.